Your browser doesn't support javascript.
loading
Low-frequency variation near common germline susceptibility loci are associated with risk of Ewing sarcoma.
Lin, Shu-Hong; Sampson, Joshua N; Grünewald, Thomas G P; Surdez, Didier; Reynaud, Stephanie; Mirabeau, Olivier; Karlins, Eric; Rubio, Rebeca Alba; Zaidi, Sakina; Grossetête-Lalami, Sandrine; Ballet, Stelly; Lapouble, Eve; Laurence, Valérie; Michon, Jean; Pierron, Gaelle; Kovar, Heinrich; Kontny, Udo; González-Neira, Anna; Alonso, Javier; Patino-Garcia, Ana; Corradini, Nadège; Bérard, Perrine Marec; Miller, Jeremy; Freedman, Neal D; Rothman, Nathaniel; Carter, Brian D; Dagnall, Casey L; Burdett, Laurie; Jones, Kristine; Manning, Michelle; Wyatt, Kathleen; Zhou, Weiyin; Yeager, Meredith; Cox, David G; Hoover, Robert N; Khan, Javed; Armstrong, Gregory T; Leisenring, Wendy M; Bhatia, Smita; Robison, Leslie L; Kulozik, Andreas E; Kriebel, Jennifer; Meitinger, Thomas; Metzler, Markus; Krumbholz, Manuela; Hartmann, Wolfgang; Strauch, Konstantin; Kirchner, Thomas; Dirksen, Uta; Mirabello, Lisa.
Afiliação
  • Lin SH; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
  • Sampson JN; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
  • Grünewald TGP; Max-Eder Research Group for Pediatric Sarcoma Biology, Ludwig Maximilians Universität (LMU), Munich, Germany.
  • Surdez D; Division of Translational Pediatric Sarcoma Research, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Reynaud S; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Mirabeau O; Inserm U830, Équipe Labellisés LNCC, PSL Université, Institut Curie, Paris, France.
  • Karlins E; SIREDO Oncology Centre, Institut Curie, Paris, France.
  • Rubio RA; Inserm U830, Équipe Labellisés LNCC, PSL Université, Institut Curie, Paris, France.
  • Zaidi S; SIREDO Oncology Centre, Institut Curie, Paris, France.
  • Grossetête-Lalami S; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
  • Ballet S; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, United States of America.
  • Lapouble E; Max-Eder Research Group for Pediatric Sarcoma Biology, Ludwig Maximilians Universität (LMU), Munich, Germany.
  • Laurence V; Inserm U830, Équipe Labellisés LNCC, PSL Université, Institut Curie, Paris, France.
  • Michon J; SIREDO Oncology Centre, Institut Curie, Paris, France.
  • Pierron G; Inserm U830, Équipe Labellisés LNCC, PSL Université, Institut Curie, Paris, France.
  • Kovar H; SIREDO Oncology Centre, Institut Curie, Paris, France.
  • Kontny U; SIREDO Oncology Centre, Institut Curie, Paris, France.
  • González-Neira A; SIREDO Oncology Centre, Institut Curie, Paris, France.
  • Alonso J; SIREDO Oncology Centre, Institut Curie, Paris, France.
  • Patino-Garcia A; SIREDO Oncology Centre, Institut Curie, Paris, France.
  • Corradini N; SIREDO Oncology Centre, Institut Curie, Paris, France.
  • Bérard PM; Children's Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria.
  • Miller J; Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, Uniklinik RWTH Aachen, Aachen, Germany.
  • Freedman ND; Human Genotyping Unit-CeGen, Human Cancer Genetics Programme, Spanish National Cancer Research Centre, Madrid, Spain.
  • Rothman N; Unidad de Tumores Solidos Infantiles (IIER-ISCIII) & Centro de Investigación Biomédica en Red de Enfermedades Raras (CB06/07/1009; CIBERER-ISCIII), Instituto de Salud Carlos III, Majadahonda, Spain.
  • Carter BD; Laboratory of Pediatrics, University Clinic of Navarra, Program in Solid Tumors, Center for Applied Medical Research (CIMA) and Navarra's Health Research Institute (IdiSNA), Pamplona, Spain.
  • Dagnall CL; Institute for Paediatric Haematology and Oncology, Leon Bérard Cancer Centre, University of Lyon, Lyon, France.
  • Burdett L; Institute for Paediatric Haematology and Oncology, Leon Bérard Cancer Centre, University of Lyon, Lyon, France.
  • Jones K; Information Management Services, Inc., Calverton, MD, United States of America.
  • Manning M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
  • Wyatt K; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
  • Zhou W; Behavioral and Epidemiology Research Group, American Cancer Society, Atlanta, GA, United States of America.
  • Yeager M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
  • Cox DG; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, United States of America.
  • Hoover RN; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
  • Khan J; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, United States of America.
  • Armstrong GT; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
  • Leisenring WM; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, United States of America.
  • Bhatia S; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
  • Robison LL; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, United States of America.
  • Kulozik AE; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
  • Kriebel J; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, United States of America.
  • Meitinger T; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
  • Metzler M; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, United States of America.
  • Krumbholz M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
  • Hartmann W; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, United States of America.
  • Strauch K; Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, France.
  • Kirchner T; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
  • Dirksen U; Genetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States of America.
  • Mirabello L; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN, United States of America.
PLoS One ; 15(9): e0237792, 2020.
Article em En | MEDLINE | ID: mdl-32881892
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcoma de Ewing / Variação Genética / Predisposição Genética para Doença / Loci Gênicos / Células Germinativas Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcoma de Ewing / Variação Genética / Predisposição Genética para Doença / Loci Gênicos / Células Germinativas Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos